We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
RANDOX LABORATORIES

Download Mobile App




Events

17 Jun 2026 - 19 Jun 2026

Software to Upgrade Sub-Saharan Blood Supply

By HospiMedica staff writers
Posted on 06 May 2004
The delivery of software to upgrade the blood supply in Sub-Saharan Africa has been announced by Global Med Technologies, Inc. More...
(Denver, CO, USA).

The two software programs were the SafeTrace donor management system and the SafeTrace Tx transfusion management system. Together they contribute to Vein-To-Vein tracking from donor collection to patient transfusion. Both are the products of Global Med's division, Wyndgate Technologies (Eldorado Hills, CA, USA; www.wyndgate.com). This delivery marks the beginning of Global Med's foray into international markets, where there are abundant opportunities to help underdeveloped countries upgrade their blood supply.

Blood centers are faced with blood shortages and an environment of possible contamination of the blood supply with blood-borne diseases, such as HIV, hepatitis, and West Nile Virus. These factors, especially the spread of HIV, are becoming drivers in the international market for blood center and transfusion services. Most blood banks and hospitals in sub-Saharan Africa utilize manual processes and maintain only manual records with little or no computer software or automation to help control the testing and safe release of blood and blood products.

Wyndgate's donor and hospital transfusion information systems, with their comprehensive safety features, will help to enhance the quality of blood products distributed throughout sub-Saharan Africa by helping to ensure that only suitable blood products are released for transfusion. Potentially, this may help to decrease the transmission rate of HIV/AIDS through blood transfusions in sub-Saharan Africa, which in turn may ultimately help to save many lives.

Mick Ruxin, M.D., chairman and CEO of Global Med Technologies stated, "This is truly a milestone for Global Med--something that the management team always believed would happen and which has the potential to catapult the company into many other countries to sell its medical software management systems.” Wyndgate has strategic marketing relationships with a number of companies in the blood services products industry. Through these partnerships, Global Med is poised to take advantage of expanded market opportunities for its blood services management software.





Related Links:
Global Med
Wyndgate

Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
Online QC Software
Acusera 24•7
New
Automated Coagulation Analyzer
Hemolumi H6
All-in-One Molecular System
AIO M160
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Researchers use a novel immobilized liposome-bound gel beads method to measure CEC levels and their association with cardiovascular risks (Photo courtesy of Institute of Science Tokyo)

Simple Blood-Based Cholesterol Efflux Assay Identifies High-Risk Coronary Plaque Features

Unstable coronary plaques are difficult to identify before they trigger acute cardiovascular events. Standard high-density lipoprotein (HDL) measurements do not always capture how well HDL particles function... Read more

Pathology

view channel
Image: Overview of the uncertainty-aware lensfree computational pathology platform for automated HER2 assessment. A compact lensfree holographic imaging system captures diffraction patterns from immunohistochemically stained breast tissue samples, which are computationally reconstructed and analyzed using deep neural networks with Bayesian uncertainty quantification. (Photo courtesy of Ozcan Lab, UCLA)

Uncertainty-Aware AI Platform Supports Automated HER2 Assessment in Breast Cancer

Accurate assessment of human epidermal growth factor receptor 2 (HER2) is critical for breast cancer diagnosis and treatment selection, yet scoring variability and infrastructure requirements can complicate... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.